BIOMAT Database Logo BIOMAT Database Logo

New antihistamines: substituted piperazine and piperidine derivatives as novel H1-antagonists. 1995

M Abou-Gharbia, and J A Moyer, and S T Nielsen, and M Webb, and U Patel
Chemical Sciences Division, Wyeth-Ayerst Research, Princeton, New Jersey 08543-8000, USA.

Structural manipulation of polycyclic piperazinyl imide serotonergic agents led to the synthesis of compound 8, 2-[4-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]-4, 4a,5,5a,6,6a-hexahydro-4,6-ethenocycloprop[f]isoindole-1,3(2H,3 aH)-dione, which demonstrated good H1-antagonist activity. Substitution of a xanthinyl moiety for the polycyclic imide group led to the identification of novel xanthinyl-substituted piperazinyl and piperidinyl derivatives with potent antihistamine H1-activity without the undesirable antidopaminergic activity of 8. One compound, 24, 7-[3-[4-(diphenylmethoxy)-1-piperidinyl]propyl]- 3,7-dihydro-1,3-dimethyl-1H-pyrine-2,6-dione (WY-49051), is a potent, orally active H1-antagonist with a long duration of action and a favorable central nervous system profile.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D010880 Piperidines A family of hexahydropyridines.
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

M Abou-Gharbia, and J A Moyer, and S T Nielsen, and M Webb, and U Patel
Novel substituted heteroaromatic piperazine and piperidine derivatives as inhibitors of human enterovirus 71 and coxsackievirus a16.
April 2013, Molecules (Basel, Switzerland),
M Abou-Gharbia, and J A Moyer, and S T Nielsen, and M Webb, and U Patel
Pyrazolone methylamino piperidine derivatives as novel CCR3 antagonists.
August 2007, Bioorganic & medicinal chemistry letters,
M Abou-Gharbia, and J A Moyer, and S T Nielsen, and M Webb, and U Patel
Antimycobacterial and H1-antihistaminic activity of 2-substituted piperidine derivatives.
December 2008, Bioorganic & medicinal chemistry,
M Abou-Gharbia, and J A Moyer, and S T Nielsen, and M Webb, and U Patel
Synthesis and pharmacological evaluation of piperidine (piperazine)-amide substituted derivatives as multi-target antipsychotics.
October 2020, Bioorganic & medicinal chemistry letters,
M Abou-Gharbia, and J A Moyer, and S T Nielsen, and M Webb, and U Patel
Synthesis and pharmacological evaluation of piperidine (piperazine)-substituted benzoxazole derivatives as multi-target antipsychotics.
November 2015, Bioorganic & medicinal chemistry letters,
M Abou-Gharbia, and J A Moyer, and S T Nielsen, and M Webb, and U Patel
Diether (substituted) piperidine derivatives as novel, histamine H3 receptor ligands.
April 2009, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
M Abou-Gharbia, and J A Moyer, and S T Nielsen, and M Webb, and U Patel
2D & 3D-QSAR Study on Novel Piperidine and Piperazine Derivatives as Acetylcholinesterase Enzyme Inhibitors.
January 2018, Current computer-aided drug design,
M Abou-Gharbia, and J A Moyer, and S T Nielsen, and M Webb, and U Patel
Design, synthesis and biological evaluation of novel piperazine derivatives as CCR5 antagonists.
January 2013, PloS one,
M Abou-Gharbia, and J A Moyer, and S T Nielsen, and M Webb, and U Patel
Exploration of novel piperazine or piperidine constructed non-covalent peptidyl derivatives as proteasome inhibitors.
January 2017, European journal of medicinal chemistry,
M Abou-Gharbia, and J A Moyer, and S T Nielsen, and M Webb, and U Patel
Design, synthesis and preliminary pharmacological evaluation of new piperidine and piperazine derivatives as cognition-enhancers.
February 2008, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!